التفاصيل البيبلوغرافية
| العنوان: |
Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. |
| المؤلفون: |
Akamatsu, Masatoshi, Yoshida, Haruhiko, Obi, Shuntaro, Sato, Shinpei, Koike, Yukihiro, Fujishima, Tomonori, Tateishi, Ryosuke, Imamura, Masatoshi, Hamamura, Keisuke, Teratani, Takuma, Shiina, Shuichiro, Ishikawa, Takashi, Omata, Masao |
| المصدر: |
Liver International; Dec2004, Vol. 24 Issue 6, p625-630, 6p |
| مصطلحات موضوعية: |
THERAPEUTIC embolization, SURGICAL hemostasis, LIVER cancer, CLINICAL trials, TUMORS |
| مستخلص: |
Abstract: Background: Transcatheter arterial embolization (TAE) may reduce the risk of hepatocellular carcinoma (H CC) recurrence when performed before percutaneous tumor ablation (PTA), either percutaneous ethanol injection therapy (PElT) or radiofrequency ablation (RFA). We conducted a randomized, controlled trial comparing the use of TAE combined with percutaneous ethanol injection therapy (TAE/PETT) to the use of PElT only to assess the effects on HCC recurrence and survival. We continued the study after the introduction of RFA and compared TAE combined with RFA (TAE/RFA) with RFA only. Methods: Between March 1997 and April 2001, 42 HCC patients were enrolled who satisfied the following inclusion criteria: (1) uninodular HCC as determined by angiography under computed tomography, (2) arterial hypervascularity, and (3) no prior history of HCC treatment. Twenty-two patients were treated with TAE/PTA (PElT, 12; RFA, 10) and 20 patients with PTA only (PElT, 14; RFA, 6). Results: There were four cases of local recurrence in the PTA-only group and none in the TAE/PTA group (P 0.043). The four patients with local recurrence were treated with PElT. None of the patients treated with RFA showed local recurrence. The effect of TAE on overall recurrence was not significant (P 0.4179). In the multivariate analysis, prior TAE was not significant for survival (P = 0.514). Conclusions: TAE has a limited use in suppressing local recurrence when performed before PElT but not before RFA. [ABSTRACT FROM AUTHOR] |
|
Copyright of Liver International is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder